go back

Washington, DC rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,737,801 · 10th–90th $562,341–$2,137,9620%20%10th90th$1,737,801Professionalmedian $562,341 · 10th–90th $562,341–$588,8440%50%90th$562,341$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $1,737,800.83 / $2,137,962.09
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $588,843.66
CareFirst
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$741,310.24 / $851,138.04 / $1,737,800.83
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$478,630.09 / $478,630.09 / $562,341.33
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$575,439.94 / $758,577.58 / $851,138.04